(Q38008566)

26 August 2017

title

Microalbuminuria as surrogate endpoint in therapeutic trials (English)

1 reference

26 August 2017

Josep Redon

1

1 reference

26 August 2017

Fernando Martinez

series ordinal

2

1 reference

26 August 2017

publication date

1 August 2012

1 reference

Current Hypertension Reports

26 August 2017

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

345-349

1 reference

Surrogate end points in clinical trials: are we being misled?

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Development of microalbuminuria in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Renal handling of albumin: a critical review of basic concepts and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Microalbuminuria as a marker of cardiovascular and renal disease in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Changes in albuminuria predict mortality and morbidity in patients with vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-012-0270-Y

Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22569647

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Introduction to surrogate markers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22569647

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Urinary albumin excretion during the night in essential arterial hypertension]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22569647

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11906-012-0270-Y

1 reference

Dimensions Publication ID

26 August 2017

1051814871

0 references

1 reference